Androgen receptor and androgen-dependent gene expression in lung

https://doi.org/10.1016/j.mce.2009.12.022Get rights and content

Abstract

The androgen receptor (AR) mediates the effects of male sex steroids. There are major sex differences in lung development and pathologies, including lung cancer. In this report, we show that Ar is mainly expressed in type II pneumocytes and the bronchial epithelium of murine lung and that androgen treatment increases AR protein levels in lung cells. Androgen administration altered significantly murine lung gene expression profiles; for example, by up-regulating transcripts involved in oxygen transport and down-regulating those in DNA repair and DNA recombination. Androgen exposure also affected the gene expression profile in a human lung adenocarcinoma-derived cell line, A549, by up- or down-regulating significantly some 200 transcripts, including down-regulation of genes involved in cell respiration. Dexamethasone treatment of A549 cells augmented expression of transcript sets that overlapped in part with those up-regulated by androgen in these cells. Moreover, a human lung cancer tissue array revealed that different lung cancer types are all AR-positive. Our results indicate that adult lung is an AR target tissue and suggest that AR plays a role in lung cancer biology.

Introduction

Lung alveoli comprise two epithelial cell types, type I and type II pneumocytes (PTI and PTII, respectively) that enable gaseous exchange. PTI cells form the majority of the epithelium, and while PTII cells account for only about 15% of peripheral lung cells (Stone et al., 1992), they serve as stem cells that produce new PTI and PTII cells and have other specialized functions. For instance, PTII cells secrete surfactant to reduce the surface tension of the alveoli and decrease the work of breathing by preventing the alveoli from collapsing. Glucocorticoid receptor (GR) is essential in promoting differentiation of PTII cells during embryonic life (Ballard, 1989, Gonzales et al., 2001, Gonzales et al., 2002) and, antenatal glucocorticoid administration expedites lung maturation in infants at risk of preterm delivery (Roberts and Dalziel, 2006), largely through increased surfactant protein expression (Ballard, 1989).

Androgen receptor (AR) mediates the effects of male sex steroids in a variety of reproductive and non-reproductive tissues both in males and females under physiological and pathophysiological conditions (Dehm and Tindall, 2006, Heemers and Tindall, 2007, Heinlein and Chang, 2002, Heinlein and Chang, 2004). Lungs of male fetuses develop more slowly than those of females, and males are more prone to neonatal respiratory distress syndrome due to reduced number of PTII cells and lack of surfactant (Perelman et al., 1986). The AR has been studied in the developing human and murine lungs, and it has been shown to influence branching morphogenesis (Kimura et al., 2003) and to attenuate PTII cell maturation (Dammann et al., 2000, Provost et al., 2000). During development, there are several differentially expressed genes in the lungs of female and male mouse fetuses, including apolipoproteins that may be involved in local lipid metabolism and transport related to surfactant lipid synthesis (Simard et al., 2006). However, the effect of androgens on the gene expression profile in adult lung has not been assessed.

Lung cancer is a disease with a clear sex difference. Female patients show better survival rates than males at any stage of the disease (Fu et al., 2005). Histological subtypes of the disease in women include proportionally more adenocarcinoma and less squamous cell carcinoma than men (Chen et al., 2005, Fu et al., 2005). Overall, men appear to have a higher rate of fatal outcome of lung cancer, but tend to be less vulnerable to tobacco carcinogens than women (International Early Lung Cancer Action Program Investigators et al., 2006). It remains to be elucidated whether these differences result from men having lower circulating female sex steroid (estrogen and progesterone) or higher androgen levels than women, or from some as yet unknown confounding associations.

There is a previous report on the presence of AR in adult human lung (Wilson and McPhaul, 1996), but very little is known about functional importance of AR and androgen signaling in lung physiology after embryonal development. To address these issues, we have examined expression of the Ar gene and searched for androgen-dependent target genes in adult murine lung. Androgen-treated A549 cells, representing a transformed human PTII adenocarcinoma cell line, were used to compare androgen-dependent gene expression profiles in human cells with those in murine lung. Since androgens and glucocorticoids are known to regulate expression of the same genes, such as the prostate-specific antigen gene (Cleutjens et al., 1997, Thompson et al., 2006), the A549 cells were also employed to examine similarities and differences between gene expression profiles regulated by androgens and glucocorticoids through the AR and GR, respectively.

Section snippets

Mice and hormone treatments

Wild-type FVB mice were used. One week after castration, one group of male mice received androgen for 5 days [1 mg testosterone (T)/mouse/day in 0.1 ml of mineral oil as sc injections, corresponding to 30 μg T/g of body weight], whereas the control group received only vehicle. The dose of the androgen was based on similar previous experiments with mice (Pajunen et al., 1982). Animals were sacrificed on day 6, and the lungs were collected for RNA and protein isolation as well as for

Lung cell expression of the Ar gene

Ar mRNA was detected in hybridization blots of total murine lung RNA as a distinct ∼10-kb band. The presence of Ar mRNA size heterogeneity has been reported previously (Tilley et al., 1990, Shan et al., 1990), with two mRNA species of ∼10 kb and ∼8 kb in size. This latter Ar mRNA species was barely detectable in murine lung but corresponded to the principal Ar mRNA from in brain (Fig. 1A). The abundance of Ar mRNA in lung was comparable to that in brain, but less than in kidney or prostate. This

Localization of AR expression to specific lung cell types

In addition to fetal lung (Dammann et al., 2000, Kimura et al., 2003, Provost et al., 2004), we have now shown that adult lung is an androgen-responsive tissue in both mice and humans, and the AR is expressed predominantly in the bronchial epithelium and PTII cells. The latter cells are important in the maintenance of alveolar epithelium by (i) providing new epithelial cells and (ii) secreting surfactant. Since T delays maturation of PTII cells during embryonic development (Provost et al., 2004

Acknowledgments

We thank Saija Kotola, Johanna Iso-Oja and Anne Reijula for excellent technical assistance, Massimiliano Gentile for helping with the microarray analysis and Ismo Virtanen for helping with histological techniques. This work was supported by grants from the Academy of Finland, Biocentrum Helsinki, Sigrid Jusélius Foundation, Finnish Foundation for Cancer Research, Paulo Foundation, Oskar Öflund Foundation, Emil Aaltonen Foundation, Finnish Medical Foundation, Helsinki University Central

References (56)

  • W.D. Tilley et al.

    Expression of the human androgen receptor gene utilizes a common promoter in diverse human tissues and cell line

    J. Biol. Chem.

    (1990)
  • G. Verrijdt et al.

    Selective DNA recognition by the androgen receptor as a mechanism for hormone-specific regulation of gene expression

    Mol. Genet. Metab.

    (2003)
  • Q. Wang et al.

    A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth

    Mol. Cell

    (2007)
  • C.M. Wilson et al.

    A and B forms of the androgen receptor are expressed in a variety of human tissues

    Mol. Cell Endocrinol.

    (1996)
  • P.L. Ballard

    Hormonal regulation of pulmonary surfactant

    Endocr. Rev.

    (1989)
  • E.C. Bolton et al.

    Cell- and gene-specific regulation of primary target genes by the androgen receptor

    Genes Dev.

    (2007)
  • T.H. Chang et al.

    Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor gamma in non-small cell lung cancer

    Cancer Res.

    (2000)
  • K.Y. Chen et al.

    Distribution according to histologic type and outcome by gender and age group in Taiwanese patients with lung carcinoma

    Cancer

    (2005)
  • C.B. Cleutjens et al.

    Both androgen receptor and glucocorticoid receptor are able to induce prostate-specific antigen expression, but differ in their growth-stimulating properties of LNCaP cells

    Endocrinology

    (1997)
  • T.J. Cole et al.

    Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation

    Genes Dev.

    (1995)
  • C.E. Dammann et al.

    Androgen regulation of signaling pathways in late fetal mouse lung development

    Endocrinology

    (2000)
  • S.M. Dehm et al.

    Molecular regulation of androgen action in prostate cancer

    J. Cell. Biochem.

    (2006)
  • L.W. Gonzales et al.

    Maintenance of differentiated function of the surfactant system in human fetal lung type II epithelial cells cultured on plastic

    Pediatr. Pathol. Mol. Med.

    (2001)
  • L.W. Gonzales et al.

    Differentiation of human pulmonary type II cells in vitro by glucocorticoid plus cAMP

    Am. J. Physiol. Lung Cell. Mol. Physiol.

    (2002)
  • R. Govindarajan et al.

    Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes

    J. Clin. Oncol.

    (2007)
  • H.V. Heemers et al.

    Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex

    Endocr. Rev.

    (2007)
  • C.A. Heinlein et al.

    Androgen receptor (AR) coregulators: an overview

    Endocr. Rev.

    (2002)
  • C.A. Heinlein et al.

    Androgen receptor in prostate cancer

    Endocr. Rev.

    (2004)
  • Cited by (200)

    View all citing articles on Scopus
    View full text